Korea Drug Stock Soars After Plaudit But There Was No Award

Bookmark
(Bloomberg) -- HLB Inc., a South Korean drugmaker, almost doubled its stock price in the past two months after saying its gastric cancer treatment was named in “The Best of ESMO 2019” list by the E...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.